Amarin Corp Plcuk (AMRN) Receivables - Other (2010 - 2018)

Amarin Corp Plcuk (AMRN) reported Receivables - Other of $25.7 million for Q3 2018, up 7208.83% quarter-over-quarter from $351000.0 in Q4 2010.

Amarin Corp Plcuk (AMRN) Receivables - Other (2010 - 2018) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 2 years of Receivables - Other data on file, last reported at $25.7 million in Q3 2018.

Receivables - Other for Q3 2018 came in at $25.7 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was $25.7 million (changed N/A YoY), and the FY2010 annual result was $351000.0, changed N/A from the prior year.
Receivables - Other climbed to $25.7 million in Q3 2018 per AMRN's latest filing, from $351000.0 in the prior quarter.
Over five years, Receivables - Other peaked at $25.7 million in Q3 2018 and troughed at $25.7 million in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn
10	Amarin Corp Plcuk	6.77 Bn	6.59 Bn	17.77 Mn

Download Data